STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS

STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS

Diğer sürümleri göster (1)

Detaylı Bibliyografya
Asıl Yazarlar:	Mesker, W, Johnstone, E, Van Pelt, G, Midgley, R, Liefers, G, Morreau, J, Kerr, D, Tollenaar, R
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	2010

Benzer Materyaller

Stroma production within the primary tumour correlates with poor survival for stage I-II colon cancer patients
Yazar:: Mesker, W, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Stroma Production Within the Primary Tumour Correlates With Poor Survival for Stage I-II Colon Cancer Patients
Yazar:: Mesker, W, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS.
Yazar:: Mesker, W, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
Yazar:: Huijbers, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

THE INTRA-TUMOR STROMA MICROENVIRONMENT IN THERAPY MANAGEMENT FOR COLON CANCER PATIENTS
Yazar:: Mesker, W, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
Yazar:: Wilma E. Mesker, ve diğerleri
Baskı/Yayın Bilgisi: (2009-01-01)

Filling the gap between microscopic and automated analysis of the tumor-stroma ratio
Yazar:: Gabi Pelt, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment
Yazar:: Marloes A. Smit, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage
Yazar:: Wilma E. Mesker, ve diğerleri
Baskı/Yayın Bilgisi: (2007-01-01)

e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study
Yazar:: Smit, Marloes A, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

The role of artificial intelligence to quantify the tumour-stroma ratio for survival in colorectal cancer
Yazar:: Marloes A Smit, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Prognosis prediction of stage II colon cancer by gene expression profiling
Yazar:: Capella, MG, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.
Yazar:: Midgley, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
Yazar:: Cor J. Ravensbergen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer
Yazar:: Takashi Okuyama, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
Yazar:: G.W. van Pelt, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Integrating Tumor Stroma Biomarkers With Clinical Indicators for Colon Cancer Survival Stratification
Yazar:: Yong Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

DSG2 expression is low in colon cancer and correlates with poor survival
Yazar:: Tingting Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Exploring prognostic values of DNA ploidy, stroma-tumor fraction and nucleotyping in stage II colon cancer patients
Yazar:: Yutong Lou, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
Yazar:: Midgley, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute<it>⊕ </it>Study
Yazar:: Pruijt Hans FM, ve diğerleri
Baskı/Yayın Bilgisi: (2011-05-01)

High expression of STAT3 within the tumour‐associated stroma predicts poor outcome in breast cancer patients
Yazar:: Elizabeth Morrow, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
Yazar:: Midgley, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Defective mismatch repair in colon cancer: A prognostic or predictive biomarker?
Yazar:: Kerr, D, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?
Yazar:: Kerr, D, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels
Yazar:: Arentz Georgia, ve diğerleri
Baskı/Yayın Bilgisi: (2011-12-01)

Cancer of the Colon and Rectum: Treatment: Chemotherapy
Yazar:: Sabharwal, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

A deep learning quantified stroma-immune score to predict survival of patients with stage II–III colorectal cancer
Yazar:: Zeyan Xu, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study
Yazar:: Tanke Hans J, ve diğerleri
Baskı/Yayın Bilgisi: (2010-04-01)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
Yazar:: Lau, Hannah Si Hui, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
Yazar:: Hannah Si Hui Lau, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Combination of DNA ploidy, stroma, and nucleotyping predicting prognosis and tailoring adjuvant chemotherapy duration in stage III colon cancer
Yazar:: Jianhong Peng, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer
Yazar:: Hyeon Jeong Oh, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

High expression of PAX8-AS1 correlates with poor prognosis and response to fluorouracil-based chemotherapy in stage II colon cancer
Yazar:: Hongsheng Fang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer
Yazar:: Dan Jiang, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
Yazar:: Koukourakis, M, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases
Yazar:: Shahid Hussain, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
Yazar:: Yanghong Ni, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Prognostic factors of overall survival for patients with stage II colon cancer
Yazar:: Harsha Trivedi, ve diğerleri
Baskı/Yayın Bilgisi: (2014-11-01)

Triple combination therapy for pancreatic cancer remodels stroma and improves survival
Yazar:: Karina Vázquez-Arreguín, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)